Fertility startup ‘rejuvenates’ human eggs to boost chances of conception

German biotech startup Ovo Labs has developed new technologies to “rejuvenate” human eggs, potentially boosting the chances of conception.  The therapeutics are designed to enhance in vitro fertilisation (IVF), one of the most transformative advances in reproductive medicine. The first baby was born via IVF more than 40 years ago. Since then, the technology has helped millions of women get pregnant. However, IVF can put significant emotional, psychological, and financial strain on patients. It is often unsuccessful on the first attempt. Some try multiple times without success. For many, IVF ultimately does not lead to parenthood. Ovo Labs wants to…This story continues at The Next Web

German biotech startup Ovo Labs has developed new technologies to “rejuvenate” human eggs, potentially boosting the chances of conception.  The therapeutics are designed to enhance in vitro fertilisation (IVF), one of the most transformative advances in reproductive medicine. The first baby was born via IVF more than 40 years ago. Since then, the technology has helped millions of women get pregnant. However, IVF can put significant emotional, psychological, and financial strain on patients. It is often unsuccessful on the first attempt. Some try multiple times without success. For many, IVF ultimately does not lead to parenthood. Ovo Labs wants to…

This story continues at The Next Web

Related Posts

DeepMind’s new research restrictions threaten AI innova...

Apr 3, 2025  0

Just Eat Takeaway acquired for €4.1Bbn in one of Dutch ...

Feb 24, 2025  0

Quantum simulations are still slow. A startup says it j...

Mar 27, 2025  0